2.70
                                            前日終値:
              $2.74
            開ける:
              $2.71
            24時間の取引高:
                126.33K
            Relative Volume:
              0.86
            時価総額:
                $101.55M
            収益:
              -
            当期純損益:
              $-13.27M
            株価収益率:
              -16.46
            EPS:
                -0.164
            ネットキャッシュフロー:
                $-7.70M
            1週間 パフォーマンス:
              +1.89%
            1か月 パフォーマンス:
              +31.71%
            6か月 パフォーマンス:
                +98.17%
            1年 パフォーマンス:
              +125.00%
            Okyo Pharma Limited Stock (OKYO) Company Profile
OKYO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS | 
|---|---|---|---|---|---|---|
| 
                         
                          
                                OKYO
                            
                             
                        Okyo Pharma Limited 
                           | 
                    2.70 | 103.05M | 0 | -13.27M | -7.70M | -0.164 | 
| 
                         
                          
                                VRTX
                            
                             
                        Vertex Pharmaceuticals Inc 
                           | 
                    426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 | 
| 
                         
                          
                                REGN
                            
                             
                        Regeneron Pharmaceuticals Inc 
                           | 
                    642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 | 
| 
                         
                          
                                ALNY
                            
                             
                        Alnylam Pharmaceuticals Inc 
                           | 
                    434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 | 
| 
                         
                          
                                ARGX
                            
                             
                        Argen X Se Adr 
                           | 
                    826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 | 
| 
                         
                          
                                INSM
                            
                             
                        Insmed Inc 
                           | 
                    186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 | 
Okyo Pharma Limited (OKYO) 最新ニュース
Will OKYO Pharma Limited (OK11) stock profit from automation waveLayoff News & Smart Swing Trading Techniques - newser.com
What sentiment indicators say about OKYO Pharma Limited stock2025 Price Targets & Free Technical Confirmation Trade Alerts - newser.com
How OKYO Pharma Limited (OK11) stock reacts to fiscal policiesDay Trade & Low Risk Investment Opportunities - newser.com
Long term hold vs stop loss in OKYO Pharma LimitedJuly 2025 Weekly Recap & Technical Buy Zone Confirmations - newser.com
Will OKYO Pharma Limited stock benefit from commodity prices2025 Biggest Moves & Trade Opportunity Analysis Reports - newser.com
How OKYO Pharma Limited stock valuations compare to rivalsJuly 2025 Big Picture & Growth-Oriented Investment Plans - newser.com
Will OKYO Pharma Limited stock deliver better than expected guidanceJuly 2025 Big Picture & Low Risk High Win Rate Stock Picks - newser.com
Will OKYO Pharma Limited (OK11) stock enhance shareholder valueGap Down & Weekly High Potential Alerts - newser.com
Is OKYO Pharma Limited stock safe for conservative investorsJuly 2025 Action & Fast Exit and Entry Strategy Plans - newser.com
What technical signals suggest for OKYO Pharma Limited stockJuly 2025 Breakouts & Safe Swing Trade Setups - newser.com
Individual investors invested in OKYO Pharma Limited (NASDAQ:OKYO) up 16% last week, insiders too were rewarded - simplywall.st
Key metrics from OKYO Pharma Limited’s quarterly dataQuarterly Profit Report & Comprehensive Market Scan Insights - newser.com
Is OKYO Pharma Limited a candidate for recovery playWeekly Volume Report & AI Forecast for Swing Trade Picks - newser.com
Will OKYO Pharma Limited (OK11) stock announce a stock split2025 Volatility Report & Technical Entry and Exit Tips - newser.com
Will OKYO Pharma Limited stock outperform Nasdaq index2025 Technical Overview & Free Fast Entry Momentum Trade Alerts - newser.com
Market reaction to OKYO Pharma Limited’s recent news2025 Trading Recap & High Accuracy Trade Signal Alerts - newser.com
Strategies to average down on OKYO Pharma Limited2025 Fundamental Recap & Verified Short-Term Plans - newser.com
Is OKYO Pharma Limited building a consolidation baseJuly 2025 News Drivers & Low Drawdown Momentum Trade Ideas - newser.com
OKYO Pharma CEO to present at BIO-Europe conference in Vienna By Investing.com - Investing.com South Africa
OKYO Pharma CEO to present at BIO-Europe conference in Vienna - Investing.com UK
OKYO Pharma to present positive Phase 2 Data for urcosimod at BIO-Europe 2025 - Proactive financial news
OKYO Pharma to Present at BIO-Europe 2025 Highlighting Urcosimod Progress - TipRanks
OKYO Pharma to Present at BIO-Europe 2025 in Vienna - The Manila Times
Okyo Pharma Limited (OKYO) 財務データ
収益
当期純利益
現金流量
EPS
                大文字化:
                 
                  | 
                ボリューム (24 時間):